Результати пошуку - Linda Borst
- Показ 1 - 4 результатів із 4
-
1
The NKG2A–HLA-E Axis as a Novel Checkpoint in the Tumor Microenvironment за авторством Linda Borst, Sjoerd H. van der Burg, Thorbald van Hall
Опубліковано 2020Revisão -
2
Monalizumab: inhibiting the novel immune checkpoint NKG2A за авторством Thorbald van Hall, Pascale André, Amir Horowitz, Dan Fu Ruan, Linda Borst, Robert Zerbib, Émilie Narni-Mancinelli, Sjoerd H. van der Burg, Éric Vivier
Опубліковано 2019Revisão -
3
<scp>NKG2A</scp> is a late immune checkpoint on <scp>CD8</scp> T cells and marks repeated stimulation and cell division за авторством Linda Borst, Marjolein Sluijter, Gregor Sturm, Pornpimol Charoentong, Saskia J. Santegoets, Mandy van Gulijk, Marit J van Elsas, Christianne Groeneveldt, Nadine van Montfoort, Francesca Finotello, Zlatko Trajanoski, Szymon M. Kiełbasa, Sjoerd H. van der Burg, Thorbald van Hall
Опубліковано 2021Artigo -
4
NKG2A Blockade Potentiates CD8 T Cell Immunity Induced by Cancer Vaccines за авторством Nadine van Montfoort, Linda Borst, Michael Korrer, Marjolein Sluijter, Koen A. Marijt, Saskia J. Santegoets, Vanessa J. van Ham, Ilina Ehsan, Pornpimol Charoentong, Pascale André, Nicolai Wagtmann, Marij J.P. Welters, Young J. Kim, Sytse J. Piersma, Sjoerd H. van der Burg, Thorbald van Hall
Опубліковано 2018Artigo
Інструменти для пошуку:
Пов'язані теми
Biochemistry
CD8
Cancer research
Cytotoxic T cell
Immune system
Immunology
In vitro
Receptor
Antibody
Biology
Blockade
Cancer
Immune checkpoint
Immunotherapy
Antigen
Chemistry
Effector
Internal medicine
Medicine
Acquired immune system
Blocking antibody
CD28
Cancer immunotherapy
Cell biology
Genetics
Human leukocyte antigen
Immunity
Major histocompatibility complex
T cell
T-cell receptor